Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piragliatin + Metformin in T2DM
NCT00266253Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of piragliatin in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Nov 2005; status: completed.
02
Drugs
piragliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00266253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266253.